logo
  • About us
    • Reig Jofre in brief
    • Strategic pillars
    • Company history
    • Locations
  • Products
    • Product categories
    • Pharmaceutical Technologies
      • Antibiotics
      • Injectable products
      • Others
    • Specialty Products
      • Dermatology
      • Osteoarticular
      • Women’s Health
      • Pediatrics
    • Consumer healthcare
    • Healthcare professionals
      and consumers corner
  • R&D
    • R&D
    • Innovation in Collaboration
    • Pipeline
    • Joint projects
  • Services
    • CDMO services
    • CMO services
  • Investors
    • Information note
    • General information
    • Inside information
    • Other relevant information
    • Former relevant facts
    • Financial information
    • Corporate governance
    • General shareholders’ meetings
    • The share
    • Analysts covering the stock
    • Presentations
    • Webcasts
  • News
    • News and repository
    • Reig Jofre in the media (ES)
    • Subscription center
  • Social Responsibility
  • Contact
    • Contact form
    • Work with us
    • Subscription center
  • |
  • ES
  • EN

News

Transparency withour stakeholders

  • Show all
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011

18 December 2015

Changes in the Board of Directors

17 November 2015

Treasury stock transactions 9M 2015

11 November 2015

Appointment of Frederic Dingeon as head of the antibiotics development and production business unit

3 November 2015

Results note: Third quarter 2015

30 October 2015

Reorganization of the delegated committees

15 October 2015

Reig Jofre starts national and international presentation roadshow

22 September 2015

Execution of the cancellation and consolidation of shares (reverse split)

17 September 2015

Reig Jofre will lead the marketing development in Europe of a nutritional supplement against tuberculosis

15 September 2015

Clarification on the reverse split date

25 August 2015

Resignation of Natra from the board of directors

17 August 2015

Treasury stock transactions 6M 2015

31 July 2015

Implementation procedures of the reverse split

30 July 2015

Reig Jofre releases the documentation of the conference presentation on 2015 first half results

30 July 2015

Results outline on the first half of 2015

27 July 2015

Cofides supports Reig Jofre international development

20 July 2015

Reig Jofre announces conference on the six-month 2015 results

22 June 2015

Reig Jofre will conclude the reverse split in September

12 June 2015

Resolutions on the general shareholders’ meeting

18 May 2015

Treasury stock operations 3M 2015

11 May 2015

Convening of General Shareholders’ Meeting 2015

  • 1
  • 2

Legal advice – Online store access for employees – RJF connected

© 2020 Laboratorio Reig Jofre

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsRead MoreAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT

Privacy Preference Center

Privacy Preferences